TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed July 9, 1976
TCL Archive NCI Proposed 1980 Budget Increases R01 Grants By $50 Million Over ’79; Total – $1.055 Billion June 9, 1978